ID ALBU_BOVIN Reviewed; 607 AA. AC P02769; A5PJX3; O02787; P04277; Q3SZR2; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1996, sequence version 4. DT 02-SEP-2026, entry version 201. DE RecName: Full=Albumin; DE AltName: Full=BSA; DE AltName: Allergen=Bos d 6; DE Flags: Precursor; GN Name=ALB; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Holowachuk E.W., Stoltenborg J.K., Reed R.G., Peters T. Jr.; RT "Bovine serum albumin: cDNA sequence and expression."; RL Submitted (AUG-1991) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-214. RC TISSUE=Liver; RA Barry T., Power S., Gannon F.; RT "The bovine serum albumin mRNA."; RL Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Liver; RX PubMed=11298124; DOI=10.1046/j.1365-2249.2001.01451.x; RA Hilger C., Grigioni F., De Beaufort C., Michel G., Freilinger J., RA Hentges F.; RT "Differential binding of IgG and IgA antibodies to antigenic determinants RT of bovine serum albumin."; RL Clin. Exp. Immunol. 123:387-394(2001). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-214. RA Wu H.T., Huang M.C.; RT "The complete cDNA sequence of bovine serum albumin."; RL Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-214. RC STRAIN=Hereford; TISSUE=Fetal liver, and Testis; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases. RN [6] RP PROTEIN SEQUENCE OF 1-32 (PRECURSOR PROTEIN). RX PubMed=488109; DOI=10.1111/j.1432-1033.1979.tb13209.x; RA McGillivray R.T.A., Chung D.W., Davie E.W.; RT "Biosynthesis of bovine plasma proteins in a cell-free system. Amino- RT terminal sequence of preproalbumin."; RL Eur. J. Biochem. 98:477-485(1979). RN [7] RP PROTEIN SEQUENCE OF 19-28. RX PubMed=843354; DOI=10.1016/0006-291x(77)91648-5; RA Patterson J.E., Geller D.M.; RT "Bovine microsomal albumin: amino terminal sequence of bovine proalbumin."; RL Biochem. Biophys. Res. Commun. 74:1220-1226(1977). RN [8] RP PARTIAL PROTEIN SEQUENCE, AND SEQUENCE REVISION TO 118-119 AND 180. RX PubMed=2260975; DOI=10.1016/s0006-291x(05)80083-x; RA Hirayama K., Akashi S., Furuya M., Fukuhara K.; RT "Rapid confirmation and revision of the primary structure of bovine serum RT albumin by ESIMS and Frit-FAB LC/MS."; RL Biochem. Biophys. Res. Commun. 173:639-646(1990). RN [9] RP PROTEIN SEQUENCE OF 25-424 AND 429-607, AND VARIANT THR-214. RA Brown J.R.; RT "Structure of bovine serum albumin."; RL Fed. Proc. 34:591-591(1975). RN [10] RP SEQUENCE REVISION TO 190-195. RA Brown J.R.; RL Submitted (APR-1975) to the PIR data bank. RN [11] RP PROTEIN SEQUENCE OF 25-64. RX PubMed=2379503; DOI=10.1111/j.1432-1033.1990.tb19092.x; RA Strawich E., Glimcher M.J.; RT "Tooth 'enamelins' identified mainly as serum proteins. Major 'enamelin' is RT albumin."; RL Eur. J. Biochem. 191:47-56(1990). RN [12] RP PROTEIN SEQUENCE OF 25-41. RX PubMed=3389500; DOI=10.1016/0003-2697(88)90082-6; RA Hsieh J.C., Lin F.P., Tam M.F.; RT "Electroblotting onto glass-fiber filter from an analytical RT isoelectrofocusing gel: a preparative method for isolating proteins for N- RT terminal microsequencing."; RL Anal. Biochem. 170:1-8(1988). RN [13] RP PROTEIN SEQUENCE OF 163-172. RX PubMed=2474609; DOI=10.4049/jimmunol.143.5.1680; RA Carraway R.E., Cochrane D.E., Boucher W., Mitra S.P.; RT "Structures of histamine-releasing peptides formed by the action of acid RT proteases on mammalian albumin(s)."; RL J. Immunol. 143:1680-1684(1989). RN [14] RP PROTEIN SEQUENCE OF 165-173. RC TISSUE=Plasma; RX PubMed=2437111; DOI=10.1016/s0021-9258(18)45523-8; RA Carraway R.E., Mitra S.P., Cochrane D.E.; RT "Structure of a biologically active neurotensin-related peptide obtained RT from pepsin-treated albumin(s)."; RL J. Biol. Chem. 262:5968-5973(1987). RN [15] RP PROTEIN SEQUENCE OF 402-433. RX PubMed=7283978; DOI=10.1042/bj1910867; RA Reed R.G., Putnam F.W., Peters T. Jr.; RT "Sequence of residues 400-403 of bovine serum albumin."; RL Biochem. J. 191:867-868(1980). RN [16] RP PROTEIN SEQUENCE OF 437-451. RA Vilbois F.; RL Submitted (AUG-1998) to UniProtKB. RN [17] RP DISULFIDE BONDS. RA Brown J.R.; RT "Structure of serum albumin: disulfide bridges."; RL Fed. Proc. 33:1389-1389(1974). RN [18] RP FUNCTION. RX PubMed=6234017; DOI=10.1021/bi00305a003; RA Konopka K., Neilands J.B.; RT "Effect of serum albumin on siderophore-mediated utilization of transferrin RT iron."; RL Biochemistry 23:2122-2127(1984). RN [19] {ECO:0007744|PDB:2L7U} RP STRUCTURE BY NMR OF 148-154, AND GLYCATION AT LYS-151. RX PubMed=21565706; DOI=10.1016/j.str.2011.02.013; RA Xue J., Rai V., Singer D., Chabierski S., Xie J., Reverdatto S., Burz D.S., RA Schmidt A.M., Hoffmann R., Shekhtman A.; RT "Advanced glycation end product recognition by the receptor for AGEs."; RL Structure 19:722-732(2011). RN [20] {ECO:0007744|PDB:4F5S} RP X-RAY CRYSTALLOGRAPHY (2.47 ANGSTROMS) OF 25-607, DISULFIDE BONDS, AND RP VARIANT THR-214. RX PubMed=22993082; DOI=10.1107/s0907444912027047; RA Bujacz A.; RT "Structures of bovine, equine and leporine serum albumin."; RL Acta Crystallogr. D 68:1278-1289(2012). RN [21] {ECO:0007744|PDB:3V03} RP X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 25-607 IN COMPLEX WITH CALCIUM, RP FUNCTION, AND DISULFIDE BONDS. RX PubMed=22677715; DOI=10.1016/j.molimm.2012.05.011; RA Majorek K.A., Porebski P.J., Dayal A., Zimmerman M.D., Jablonska K., RA Stewart A.J., Chruszcz M., Minor W.; RT "Structural and immunologic characterization of bovine, horse, and rabbit RT serum albumins."; RL Mol. Immunol. 52:174-182(2012). RN [22] {ECO:0007744|PDB:4JK4} RP X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 25-607 IN COMPLEX WITH CALCIUM, RP AND DISULFIDE BONDS. RX PubMed=23769932; DOI=10.1016/j.ijbiomac.2013.06.004; RA Sekula B., Zielinski K., Bujacz A.; RT "Crystallographic studies of the complexes of bovine and equine serum RT albumin with 3,5-diiodosalicylic acid."; RL Int. J. Biol. Macromol. 60:316-324(2013). RN [23] {ECO:0007744|PDB:4OR0} RP X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS) OF 25-607, AND DISULFIDE BONDS. RX PubMed=24753230; DOI=10.1002/prot.24583; RA Bujacz A., Zielinski K., Sekula B.; RT "Structural studies of bovine, equine, and leporine serum albumin complexes RT with naproxen."; RL Proteins 82:2199-2208(2014). CC -!- FUNCTION: Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, CC bilirubin and drugs. Its main function is the regulation of the CC colloidal osmotic pressure of blood. Major zinc transporter in plasma, CC typically binds about 80% of all plasma zinc (By similarity). Major CC calcium and magnesium transporter in plasma, binds approximately 45% of CC circulating calcium and magnesium in plasma (Probable). Potentially has CC more than two calcium-binding sites and might additionally bind calcium CC in a non-specific manner (PubMed:22677715). The shared binding site CC between zinc and calcium at residue Asp-272 suggests a crosstalk CC between zinc and calcium transport in the blood (Probable). The rank CC order of affinity is zinc > calcium > magnesium (Probable). Binds to CC the bacterial siderophore enterobactin and inhibits enterobactin- CC mediated iron uptake of E.coli, and may thereby limit the utilization CC of iron and growth of enteric bacteria such as E.coli (PubMed:6234017). CC Does not prevent iron uptake by the bacterial siderophore aerobactin CC (PubMed:6234017). {ECO:0000250|UniProtKB:P02768, CC ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:6234017, CC ECO:0000305|PubMed:22677715}. CC -!- SUBUNIT: Interacts with FCGRT; this interaction regulates ALB CC homeostasis (By similarity). In plasma, occurs in a covalently-linked CC complex with chromophore-bound alpha-1-microglobulin; this interaction CC does not prevent fatty acid binding to ALB. CC {ECO:0000250|UniProtKB:P02768}. CC -!- INTERACTION: CC P02769; Q9BXI9-2: C1QTNF6; Xeno; NbExp=4; IntAct=EBI-2296927, EBI-27104631; CC P02769; P08603: CFH; Xeno; NbExp=10; IntAct=EBI-2296927, EBI-1223708; CC P02769; PRO_0000009136 [O00602]: FCN1; Xeno; NbExp=2; IntAct=EBI-2296927, EBI-11784425; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Plasma. CC -!- PTM: Phosphorylated by FAM20C in the extracellular medium. CC {ECO:0000250|UniProtKB:P02768}. CC -!- ALLERGEN: Can cause allergic reactions in humans. CC -!- SIMILARITY: Belongs to the ALB/AFP/VDB family. {ECO:0000255|PROSITE- CC ProRule:PRU00769}. CC -!- CAUTION: A peptide arising from positions 165 to 173 was originally CC termed neurotensin-related peptide (NRP) and was thought to regulate CC fat digestion, lipid absorption, and blood flow. CC {ECO:0000305|PubMed:2437111}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M73993; AAA51411.1; -; mRNA. DR EMBL; X58989; CAA41735.1; -; mRNA. DR EMBL; Y17769; CAA76847.1; -; mRNA. DR EMBL; AF542068; AAN17824.1; -; mRNA. DR EMBL; BC102742; AAI02743.1; -; mRNA. DR EMBL; BC142272; AAI42273.1; -; mRNA. DR PIR; A38885; ABBOS. DR RefSeq; NP_851335.1; NM_180992.2. DR PDB; 2L7U; NMR; -; B=148-154. DR PDB; 3V03; X-ray; 2.70 A; A/B=25-607. DR PDB; 4F5S; X-ray; 2.47 A; A/B=25-607. DR PDB; 4JK4; X-ray; 2.65 A; A/B=25-607. DR PDB; 4OR0; X-ray; 2.58 A; A/B=25-607. DR PDB; 6QS9; X-ray; 2.80 A; A/B=1-607. DR PDB; 6RJV; X-ray; 3.21 A; A/B=25-607. DR PDB; 8KFO; X-ray; 3.60 A; A/B=1-607. DR PDB; 8WDD; X-ray; 3.90 A; A/B=25-607. DR PDB; 9QQD; EM; 3.10 A; A=28-605. DR AlphaFoldDB; P02769; -. DR BMRB; P02769; -. DR EMDB; EMD-10794; -. DR EMDB; EMD-53298; -. DR MDRepo; P02769; -. DR SASBDB; P02769; -. DR SMR; P02769; -. DR BioGRID; 158123; 5. DR FunCoup; P02769; 275. DR IntAct; P02769; 15. DR STRING; 9913.ENSBTAP00000022763; -. DR BindingDB; P02769; -. DR ChEMBL; CHEMBL3728; -. DR DrugCentral; P02769; -. DR Allergome; 165; Bos d 6. DR Allergome; 3166; Bos d 6.0101. DR CarbonylDB; P02769; -. DR GlyCosmos; P02769; 1 site, No reported glycans. DR GlyGen; P02769; 1 site, 1 O-linked glycan (1 site). DR PaxDb; 9913-ENSBTAP00000022763; -. DR PeptideAtlas; P02769; -. DR PRIDE; P02769; -. DR ABCD; P02769; 3 sequenced antibodies. DR GeneID; 280717; -. DR KEGG; bta:280717; -. DR CTD; 213; -. DR eggNOG; ENOG502R7EA; Eukaryota. DR HOGENOM; CLU_030161_0_0_1; -. DR InParanoid; P02769; -. DR OrthoDB; 9875082at2759; -. DR SABIO-RK; P02769; -. DR EvolutionaryTrace; P02769; -. DR PRO; PR:P02769; -. DR Proteomes; UP000009136; Unplaced. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB. DR GO; GO:0003677; F:DNA binding; ISS:UniProtKB. DR GO; GO:1903981; F:enterobactin binding; IDA:UniProtKB. DR GO; GO:0005504; F:fatty acid binding; ISS:UniProtKB. DR GO; GO:0030170; F:pyridoxal phosphate binding; ISS:UniProtKB. DR GO; GO:0015643; F:toxic substance binding; ISS:UniProtKB. DR GO; GO:0072732; P:cellular response to calcium ion starvation; ISS:UniProtKB. DR GO; GO:0009267; P:cellular response to starvation; ISS:UniProtKB. DR GO; GO:0051902; P:negative regulation of mitochondrial depolarization; ISS:UniProtKB. DR GO; GO:0031667; P:response to nutrient levels; IBA:GO_Central. DR CDD; cd00015; ALBUMIN; 3. DR FunFam; 1.10.246.10:FF:000001; Serum albumin; 2. DR FunFam; 1.10.246.10:FF:000002; Serum albumin; 2. DR FunFam; 1.10.246.10:FF:000003; Serum albumin; 1. DR Gene3D; 1.10.246.10; -; 6. DR InterPro; IPR000264; ALB/AFP/VDB. DR InterPro; IPR020858; Serum_albumin-like. DR InterPro; IPR021177; Serum_albumin/AFP/Afamin. DR InterPro; IPR020857; Serum_albumin_CS. DR InterPro; IPR014760; Serum_albumin_N. DR PANTHER; PTHR11385:SF15; ALBUMIN; 1. DR PANTHER; PTHR11385; SERUM ALBUMIN-RELATED; 1. DR Pfam; PF00273; Serum_albumin; 3. DR PIRSF; PIRSF002520; Serum_albumin_subgroup; 1. DR PRINTS; PR00803; AFETOPROTEIN. DR PRINTS; PR00802; SERUMALBUMIN. DR SMART; SM00103; ALBUMIN; 3. DR SUPFAM; SSF48552; Serum albumin-like; 3. DR PROSITE; PS00212; ALBUMIN_1; 3. DR PROSITE; PS51438; ALBUMIN_2; 3. PE 1: Evidence at protein level; KW 3D-structure; Allergen; Calcium; Cleavage on pair of basic residues; KW Copper; Direct protein sequencing; Disulfide bond; Glycation; Glycoprotein; KW Lipid-binding; Metal-binding; Methylation; Phosphoprotein; KW Reference proteome; Repeat; Secreted; Signal; Zinc. FT SIGNAL 1..18 FT /evidence="ECO:0000269|PubMed:843354" FT PROPEP 19..24 FT /id="PRO_0000001057" FT CHAIN 25..607 FT /note="Albumin" FT /id="PRO_0000001058" FT DOMAIN 19..209 FT /note="Albumin 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769" FT DOMAIN 210..402 FT /note="Albumin 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769" FT DOMAIN 403..600 FT /note="Albumin 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769" FT BINDING 27 FT /ligand="Cu cation" FT /ligand_id="ChEBI:CHEBI:23378" FT /evidence="ECO:0000250|UniProtKB:P02770" FT BINDING 30 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0007744|PDB:3V03" FT BINDING 37 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0000269|PubMed:23769932, ECO:0007744|PDB:3V03, FT ECO:0007744|PDB:4JK4" FT BINDING 91 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250|UniProtKB:P02768" FT BINDING 267 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0000269|PubMed:23769932, ECO:0007744|PDB:3V03, FT ECO:0007744|PDB:4JK4" FT BINDING 270 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250|UniProtKB:P02768" FT BINDING 272 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0007744|PDB:3V03" FT BINDING 272 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000250|UniProtKB:P02768" FT BINDING 275 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0000269|PubMed:23769932, ECO:0007744|PDB:3V03, FT ECO:0007744|PDB:4JK4" FT BINDING 278 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0000269|PubMed:23769932, ECO:0007744|PDB:3V03, FT ECO:0007744|PDB:4JK4" FT BINDING 282 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:22677715, FT ECO:0000269|PubMed:23769932, ECO:0007744|PDB:3V03, FT ECO:0007744|PDB:4JK4" FT MOD_RES 29 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 82 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 89 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 107 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 228 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P07724" FT MOD_RES 296 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P07724" FT MOD_RES 442 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 443 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 445 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 512 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 557 FT /note="N6-methyllysine" FT /evidence="ECO:0000250|UniProtKB:P02768" FT MOD_RES 569 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P02770" FT MOD_RES 587 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P07724" FT CARBOHYD 151 FT /note="N-linked (Glc) (glycation) lysine; in vitro" FT /evidence="ECO:0000269|PubMed:21565706" FT DISULFID 77..86 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 99..115 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 114..125 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 147..192 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 191..200 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 223..269 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 268..276 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 288..302 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 301..312 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 339..384 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 383..392 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 415..461 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 460..471 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 484..500 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 499..510 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 537..582 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT DISULFID 581..590 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00769, FT ECO:0000269|PubMed:22677715, ECO:0000269|PubMed:22993082, FT ECO:0000269|PubMed:23769932, ECO:0000269|Ref.17, FT ECO:0007744|PDB:3V03, ECO:0007744|PDB:4F5S, FT ECO:0007744|PDB:4JK4, ECO:0007744|PDB:4OR0" FT VARIANT 214 FT /note="A -> T" FT /evidence="ECO:0000269|PubMed:22993082, ECO:0000269|Ref.2, FT ECO:0000269|Ref.4, ECO:0000269|Ref.5, ECO:0000269|Ref.9" FT CONFLICT 58 FT /note="Missing (in Ref. 11; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 116 FT /note="E -> A (in Ref. 5; AAI02743)" FT /evidence="ECO:0000305" FT CONFLICT 173 FT /note="Y -> L (in Ref. 14; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 302 FT /note="C -> K (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 304..305 FT /note="KP -> PC (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 324 FT /note="N -> D (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 394..395 FT /note="ST -> TS (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 429 FT /note="A -> E (in Ref. 5; AAI02743)" FT /evidence="ECO:0000305" FT CONFLICT 437 FT /note="K -> R (in Ref. 16; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 472 FT /note="T -> A (in Ref. 5; AAI02743)" FT /evidence="ECO:0000305" FT CONFLICT 493..494 FT /note="SE -> ES (in Ref. 9; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 579 FT /note="D -> G (in Ref. 5; AAI02743)" FT /evidence="ECO:0000305" FT HELIX 30..38 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 40..54 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 56..58 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 60..79 FT /evidence="ECO:0007829|PDB:4F5S" FT TURN 84..87 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 90..99 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 104..108 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 109..116 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 121..127 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 136..139 FT /evidence="ECO:0007829|PDB:3V03" FT HELIX 143..152 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 154..168 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 169..171 FT /evidence="ECO:0007829|PDB:9QQD" FT HELIX 174..191 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 194..196 FT /evidence="ECO:0007829|PDB:4OR0" FT HELIX 197..229 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 231..245 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 247..249 FT /evidence="ECO:0007829|PDB:9QQD" FT HELIX 251..269 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 273..288 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 291..294 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 296..298 FT /evidence="ECO:0007829|PDB:4JK4" FT HELIX 301..303 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 306..315 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 316..322 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 325..327 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 329..332 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 338..344 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 346..360 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 366..385 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 386..388 FT /evidence="ECO:0007829|PDB:4JK4" FT HELIX 389..393 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 396..403 FT /evidence="ECO:0007829|PDB:4F5S" FT TURN 404..407 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 408..437 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 443..460 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 461..463 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 465..489 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 494..502 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 507..512 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 518..520 FT /evidence="ECO:0007829|PDB:4JK4" FT HELIX 521..525 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 527..530 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 534..537 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 541..558 FT /evidence="ECO:0007829|PDB:4F5S" FT HELIX 564..583 FT /evidence="ECO:0007829|PDB:4F5S" FT STRAND 584..586 FT /evidence="ECO:0007829|PDB:4OR0" FT HELIX 587..606 FT /evidence="ECO:0007829|PDB:4F5S" SQ SEQUENCE 607 AA; 69293 MW; 39167DFE768585D4 CRC64; MKWVTFISLL LLFSSAYSRG VFRRDTHKSE IAHRFKDLGE EHFKGLVLIA FSQYLQQCPF DEHVKLVNEL TEFAKTCVAD ESHAGCEKSL HTLFGDELCK VASLRETYGD MADCCEKQEP ERNECFLSHK DDSPDLPKLK PDPNTLCDEF KADEKKFWGK YLYEIARRHP YFYAPELLYY ANKYNGVFQE CCQAEDKGAC LLPKIETMRE KVLASSARQR LRCASIQKFG ERALKAWSVA RLSQKFPKAE FVEVTKLVTD LTKVHKECCH GDLLECADDR ADLAKYICDN QDTISSKLKE CCDKPLLEKS HCIAEVEKDA IPENLPPLTA DFAEDKDVCK NYQEAKDAFL GSFLYEYSRR HPEYAVSVLL RLAKEYEATL EECCAKDDPH ACYSTVFDKL KHLVDEPQNL IKQNCDQFEK LGEYGFQNAL IVRYTRKVPQ VSTPTLVEVS RSLGKVGTRC CTKPESERMP CTEDYLSLIL NRLCVLHEKT PVSEKVTKCC TESLVNRRPC FSALTPDETY VPKAFDEKLF TFHADICTLP DTEKQIKKQT ALVELLKHKP KATEEQLKTV MENFVAFVDK CCAADDKEAC FAVEGPKLVV STQTALA //